| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 78, 1225-1231, Copyright © 1994 by Endocrine Society
ARTICLES |
SH Woodworth, X Li, ZM Lei, CV Rao, MA Yussman, JA Spinnato 2nd, C Yokoyama, T Tanabe and V Ullrich
Department of Obstetrics and Gynecology, University of Louisville School of Medicine, Kentucky 40292.
Preeclampsia is a disease of late pregnancy characterized by hypertension, edema, and proteinuria, in which vasoconstriction, platelet aggregation, and reduced uteroplacental blood flow contribute to preterm delivery, perinatal morbidity, and mortality. Increased thromboxane-A2 (TXA2) and/or decreased prostacyclin (PGI2) have been implicated as causative factors of this disease. The present studies investigated the expression of TXA2 synthase gene along with those of TXA2 receptors, PGI2 synthase, cyclooxygenase-1 (COX-1), and COX-2 in placental and decidual tissue from preeclamptic and normal pregnancies. In situ hybridization and immunocytochemistry showed that primarily trophoblast layer and decidual cells express TXA2 synthase, COX-1, and COX-2 enzymes. Immunocytochemistry for PGI2 synthase and in situ hybridization for TXA2 receptors showed similar results. Trophoblast layer and decidua from preeclamptic pregnancies contained a greater abundance of mRNA and protein of TXA2 synthase than the matched normal pregnancies. In summary, our findings suggest that an increased local expression of TXA2 synthase could be responsible for local and/or peripheral vascular changes in preeclampsia.
This article has been cited by other articles:
![]() |
S.-T. J. HUANG, K. C. T. VO, D. J. LYELL, G. H. FAESSEN, S. TULAC, R. TIBSHIRANI, A. J. GIACCIA, and L. C. GIUDICE Developmental response to hypoxia FASEB J, September 1, 2004; 18(12): 1348 - 1365. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kriston, R. C. Venuto, C. Baylis, and G. Losonczy Hemodynamic and renal effects of U-46619, a TXA2/PGH2 analog, in late-pregnant rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1999; 276(3): R831 - R837. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Johnson, Y. Sadovsky, C. Graham, E. Y. Anteby, K. L. Polakoski, X. Huang, and D. M. Nelson The Expression and Activity of Prostaglandin H Synthase-2 Is Enhanced in Trophoblast from Women with Preeclampsia J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 3059 - 3062. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |